These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9371815)

  • 1. Btk dosage determines sensitivity to B cell antigen receptor cross-linking.
    Satterthwaite AB; Cheroutre H; Khan WN; Sideras P; Witte ON
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13152-7. PubMed ID: 9371815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.
    Nisitani S; Satterthwaite AB; Akashi K; Weissman IL; Witte ON; Wahl MI
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2737-42. PubMed ID: 10688914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
    Petro JB; Rahman SM; Ballard DW; Khan WN
    J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-mediated expression of Btk in hematopoietic stem cells is not sufficient to restore B cell function in X-linked immunodeficient mice.
    Tanabe H; Miyake K; Shimada T
    J Nippon Med Sch; 2005 Aug; 72(4):203-12. PubMed ID: 16113490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region.
    Drabek D; Raguz S; De Wit TP; Dingjan GM; Savelkoul HF; Grosveld F; Hendriks RW
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):610-5. PubMed ID: 9012832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective B cell development and function in Btk-deficient mice.
    Khan WN; Alt FW; Gerstein RM; Malynn BA; Larsson I; Rathbun G; Davidson L; Müller S; Kantor AB; Herzenberg LA
    Immunity; 1995 Sep; 3(3):283-99. PubMed ID: 7552994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
    Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL
    Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
    Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
    Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Btk function in B cell development and response.
    Satterthwaite AB; Li Z; Witte ON
    Semin Immunol; 1998 Aug; 10(4):309-16. PubMed ID: 9695187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer.
    Yu PW; Tabuchi RS; Kato RM; Astrakhan A; Humblet-Baron S; Kipp K; Chae K; Ellmeier W; Witte ON; Rawlings DJ
    Blood; 2004 Sep; 104(5):1281-90. PubMed ID: 15142874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
    Takeshita H; Taniuchi I; Kato J; Watanabe T
    Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
    Anderson JS; Teutsch M; Dong Z; Wortis HH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
    Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
    Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Bruton's tyrosine kinase in B cell development.
    Maas A; Hendriks RW
    Dev Immunol; 2001; 8(3-4):171-81. PubMed ID: 11785667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
    J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
    Brunner C; Kreth HW; Ochs HD; Schuster V
    J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired expansion of mouse B cell progenitors lacking Btk.
    Kerner JD; Appleby MW; Mohr RN; Chien S; Rawlings DJ; Maliszewski CR; Witte ON; Perlmutter RM
    Immunity; 1995 Sep; 3(3):301-12. PubMed ID: 7552995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.